Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours

This study has been completed.
Information provided by (Responsible Party):
AstraZeneca Identifier:
First received: September 16, 2009
Last updated: June 25, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2015
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)